NSF award 2553227 · California State L A University Auxiliary Services Inc.

ERI: A Multimodal Embedding Framework for Enhanced In Silico Antimicrobial Peptide Discovery

Final report due

28 August 2028

in 680 days · The award ends on 30 April 2028.

GrantClerk is a private service. We are not NSF or any government agency.

Dates this award owes

NSF emails you about this too.

Decide about an extension1 Jan 2028in 440 days
award ending 2028-04-30 · Research.gov
This one is ours, not NSF’s.
Extension request16 Mar 2028in 515 days
award ending 2028-04-30 · Research.gov
PAPPG 24-1: “at least 45 days prior to the end date”
No-cost extension notice20 Apr 2028in 550 days
award ending 2028-04-30 · Research.gov
PAPPG 24-1: “at least ten calendar days prior to the end date”
Final report due28 Aug 2028in 680 days
award ending 2028-04-30 · Research.gov
PAPPG 24-1: “no later than 120-days following the end date of the award”
Project outcomes report due28 Aug 2028in 680 days
award ending 2028-04-30 · Research.gov
PAPPG 24-1: “no later than 120 days following the end date”
Award is closed out28 Aug 2028in 680 days
award ending 2028-04-30 · Research.gov
PAPPG 24-1: “financially closed out 120 days after their expiration date”

Annual report dates come from the budget period on your award notice. That date is not public, so it is not shown here.

How we got this date

NSF lists this award's end date as 30 April 2028.
NSF rules say the final report is due no later than 120 days after that.
So the final report is due by 28 August 2028.

Read the rule on Research.gov

Get a note before each report date

Add this award to your desk. We email you before each date and keep the dates in one place.

Renews each year until you cancel. Cancel any time from your account.

Already a member? Sign in

Award card

Award number: 2553227
Period of support: 1 May 2026 – 30 Apr 2028
Amount: $199,868
Awardee: California State L A University Auxiliary Services Inc., LOS Angeles, CA
Program: Special Initiatives
Directorate: ENG

Abstract

Antibiotic resistance threatens human health. It limits treatment options for infections. It compromises the ability to safely perform surgical procedures. Most antibiotics are small molecules that kill or limit the growth of bacteria. Peptides are short protein fragments, usually between 2 and 30 amino acids in length. Some result from digestion of larger proteins. Others are produced by the immune systems of many…

Is this right?

We copy this from the public NSF award record. Your award notice and NSF always win. If a date looks wrong, check Research.gov.